Poclight Biotechnology

Puguang Biotechnology Co., Ltd. is an innovative R&D enterprise focusing on the development of in vitro medical diagnosis (IVD) platform, with a R&D and production site of 5,000 square meters, including more than 3,700 square meters of GMP workshops of 10,000 and 100,000 levels. Relying on the self-developed patented platform of "Chemiluminescence Resonance Energy Transfer (CRET)", the company has developed a variety of homogeneous chemiluminescence immunoassay products, covering clinical medicine, veterinary medicine, drug testing and other fields, with the characteristics of "precision, accuracy, low cost, fast, small and excellent". Adhering to the concept of "innovation, integration, focus and win-win". Competitive Advantage Puguang Biotechnology Co., Ltd. is fully committed to the R&D and industrialization of "Chemiluminescence Resonance Energy Transfer" (CRET) technology, and our company has obtained the authorization of this patent, which is the only one in the world. Our company has obvious competitive advantages in the IVD industry, which is mainly reflected in the following aspects: 1. The world's leading fifth-generation chemiluminescence technology At the technical level, the fifth-generation chemiluminescence immunoassay technology is exclusive to the world, which belongs to the underlying technology upgrade, and the company has complete intellectual property rights. 2. Supporting trace chemiluminescence to achieve full detection project coverage In terms of products, we have achieved extremely simplified and unique product design, which not only improves product performance, but also greatly reduces costs and improves the user experience of all links, whether it is a terminal or an agent. 3. Traditional POCT technology replaces innovation In terms of market, fully polish technology and products in the field of veterinary medicine; At the same time, the products are extremely compatible with the international market, and the foreign business supports the domestic clinical business to achieve differentiated competition